PPC

No se han encontrado resultados

Grau S, Vela JM, Gurt A, Barceló-Vidal J, Ojeda F, López I, Gómez-García L, Loza MI, Martín-García E, Maldonado R, Monfort J. Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients. Journal of Infection 2024; 88(2): 187-190.

Cajiao-Manrique MDM, Maldonado R, Martín-García E. A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction. Frontiers in Pharmacology 2023; 14( ).

Oliveras-Cañellas N, Castells-Nobau A, de la Vega-Correa L, Latorre-Luque J, Motger-Albertí A, Arnoriaga-Rodriguez M, Garre-Olmo J, Zapata-Tona C, Coll-Martínez C, Ramió-Torrentà L, Moreno-Navarrete JM, Puig J, Villarroya F, Ramos R, Casadó-Anguera V, Martín-García E, Maldonado R, Mayneris-Perxachs J, Fernández-Real JM. Adipose tissue coregulates cognitive function. Science Advances 2023; 9(32).

Fructuoso M, Fernández-Blanco Á, Gallego-Román A, Sierra C, de Lagrán MM, Lorenzon N, De Toma I, Langohr K, Martín-García E, Maldonado R, Dairou J, Janel N, Dierssen M. Exploring the link between hedonic overeating and prefrontal cortex dysfunction in the Ts65Dn trisomic mouse model. Cellular and Molecular Life Sciences 2023; 80(12).

Martinez-Torres S.; Bergada-Martinez A.; Ortega J.E.; Galera-Lopez L.; Hervera A.; de los Reyes-Ramirez L.; Ortega-Alvaro A.; Remmers F.; Muñoz-Moreno E.; Soria G.; del Rio J.A.; Lutz B.; Ruiz-Ortega J.A.; Meana J.J.; Maldonado R.; Ozaita A.. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism. Neuropsychopharmacology 2023; 48(2): 341-50.

Garcia-Blanco A, Ramirez-Lopez, Navarrete F, Garcia-Gutierrez MS, Manzanares J, Martin-Garcia E, Maldonado R. Role of CB2 cannabinoid receptor in the development of food addiction in male mice. Neurobiology of Disease 2023; 179(0).

Barrera-Conde M.; Veza-Estevez E.; Gomis-Gonzalez M.; Garcia-Quintana J.; Trabsa A.; Martinez-Sadurni L.; Pujades M.; Perez V.; de la Torre R.; Berge D.; Robledo P.. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids. Neurobiology of Disease 2023; 176( ).

Haney M, Vallée M, Fabre S, Collins Reed S, Zanese M, Campistron G, et al. Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature Medicine 2023; 29(6): 1487-99.

Cajiao-Manrique MM, Casadó-Anguera V, García-Blanco A, Maldonado R, Martín-García E. THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model. Frontiers in Psychiatry 2023; 14( ).